Ledger.

Startup · $32.5m raised

Prota Therapeutics

Melbourne, VIC

Coverage

Stories naming Prota Therapeutics. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Unnamed stage ~$7.5m

SYNthesis BioVentures Newsletter no. 3

SYNthesis BioVentures' third investor letter reports a roughly A$7.5m first close for Alzheimer's biotech S2N, lists co-investors, and profiles managing director Amir's career across OneVentures, Ceres Capital and other life-sciences roles.

4 deals

Four Aussie startups that have raised $94.5 million already in January

Roundup of January 2024 funding: Futurerent, Prota Therapeutics, National Renewable Network and Getmee together secured $94.5 million across debt, equity and a government grant, with investor details for each deal.

Series A $32m

Allergies biotech startup Prota Therapeutics innoculated with $32 million in Series A1 raise

Prota Therapeutics, a Melbourne biotech, has secured $32 million in equity and debt ahead of a Phase 3 trial of its peanut allergy therapy, with Singapore's SPRIM Global Investments leading the round.

Also SmartCompany·SmartCompany·SmartCompany·Business News Australia·Forbes Australia

35 deals

FUNDED MARCH 2022

Techboard's March 2022 roundup of Australian funding: megadeals by Immutable, Saluda Medical, Linktree and Zeller, many smaller raises, acquisitions, an IPO, several fund closes, and companies still seeking capital.

Also SmartCompany·Australian FinTech

43 deals

Ignition Lane's Weekly Wrap: The Great Reengagement, backing Web3, riding the markets & the big local raises

Ignition Lane's weekly tech roundup: AirTree raises $700m across three new funds, dozens of Australian startups announce rounds, a wave of acquisitions including Block completing its Afterpay buy, plus Web3 commentary and US market moves.

Also SmartCompany·Startup Daily·Startup Daily

Something wrong? Tell us